Janssen Pharmaceutica N.V. Janssen-Cilag S.p.A. Lusomedicamenta - Sociedade Tecnica Farmaceutica S.A.
PolandAll drugs from this manufacturer
-
It is used as monotherapy for the treatment of seizures in adults and children over 6 years of age, as an adjunctive therapy for epilepsy in children from 2 years of age, and for the prevention of migraine attacks in adults.
Dosage form: tablets, film-coated
Active substance Dosage topiramate 25 mg ATC: N03AX11
-
The medicine is used as monotherapy in the treatment of seizures in adults and children over 6 years of age, as adjunctive therapy for seizures in adults and children over 2 years of age, and for the prevention of migraine attacks in adults.
Dosage form: tablets, film-coated
Active substance Dosage topiramate 50 mg ATC: N03AX11
-
The medicine is used as monotherapy in the treatment of seizures in adults and children over 6 years of age, as adjunctive therapy for seizures in adults and children over 2 years of age, and for the prevention of migraine attacks in adults.
Dosage form: tablets, film-coated
Active substance Dosage topiramate 100 mg ATC: N03AX11
-
The medicinal product is used as monotherapy in the treatment of seizures in adults and children over 6 years of age, as adjunctive therapy for seizures in adults and children over 2 years of age, and for the prevention of migraine attacks in adults.
Dosage form: tablets, film-coated
Active substance Dosage topiramate 200 mg ATC: N03AX11